Position in CNTX
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$3,587,285
+$1,222,606 QoQ
Shares Held
2,440,330
0.0% QoQ
Ownership
2.66%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Blackstone Inc. holds $185,974,784 across 43 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUTL |
Autolus Therapeutics plc
|
20,485,611 | $28,270,143 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
292,847 | $14,771,202 | |
| 3 | DMRA |
Damora Therapeutics, Inc.
|
503,522 | $13,041,219 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
231,282 | $12,193,187 | |
| 5 | TARA |
Protara Therapeutics, Inc.
|
2,265,514 | $11,803,327 | |
| 6 | ALXO |
Alx Oncology Holdings Inc
|
5,826,544 | $11,682,220 | |
| 7 | XFOR |
X4 Pharmaceuticals, Inc
|
2,681,922 | $11,076,337 | |
| 8 | IKT |
Inhibikase Therapeutics, Inc.
|
5,938,276 | $9,976,303 |
All Filings in CNTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3,587,285 | 2,440,330 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,364,679 | 2,440,330 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,598,416 | 2,440,330 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,493,481 | 2,440,330 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,562,346 | 2,440,330 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,783,046 | 2,440,330 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $3,686,611 | 1,838,709 | Shares | Other | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||